{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T21:26:31Z","timestamp":1774128391189,"version":"3.50.1"},"reference-count":23,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2014,3,5]]},"abstract":"<jats:p>A 41-year-old nulliparous woman, with a medical history of unexplained infertility and multiple in vitro fertilisation (IVF) cycles with immunosuppressive therapy, was admitted to our tertiary obstetrics unit with sepsis at 18\u2005weeks of pregnancy with dichorionic diamniotic twins.<jats:italic>Candida glabrata<\/jats:italic>was grown from her blood cultures, then subsequently from the liquor and placentae. She was treated with intravenous ambisome (amphotericin), but unfortunately, the infection resulted in the rupture of her membranes, preterm labour and the demise of her twins. She delivered both twins at 23\u2005weeks, 3\u2005days apart. The antifungal agent was changed to high-dose fluconazole after delivery for 2\u2005weeks and she is now well. Women undergoing IVF-embryo transfer with immunomodulation therapy have a potential risk of developing candidal chorioamnionitis and sepsis.<\/jats:p>","DOI":"10.1136\/bcr-2013-203202","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T13:50:12Z","timestamp":1396273812000},"page":"bcr2013203202","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Severe systemic candidiasis following immunomodulation therapy in in vitro fertilisation-embryo transfer (IVF-ET)"],"prefix":"10.1136","volume":"2014","author":[{"given":"Folasade","family":"Akhanoba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"MacDougall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wassim","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2014,3,31]]},"reference":[{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.1","first-page":"9","article-title":"Candida chorioamnionitis diagnosed by amniocentesis with subsequent fetal infection","volume":"38","author":"Joseph","year":"2006","journal-title":"Rev Argent Microbiol"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/13.1.146"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis936"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.4","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-003-1051-y"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.1997.tb02225.x"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.07.1095"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.7","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.8","first-page":"889","article-title":"Increasing clinical pregnancy rates after IVF\/ET. Can immunosuppression help","volume":"41","author":"Mottla","year":"1996","journal-title":"J Reprod Med"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.12.1.80","article-title":"Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans","volume":"12","author":"Fidel","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.10","doi-asserted-by":"publisher","DOI":"10.3109\/13693786.2012.662597"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.11","doi-asserted-by":"publisher","DOI":"10.1080\/00365540500372952"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.17305\/bjbms.2010.2744","article-title":"Candida albicans and non-albicans species as etiological agent of vaginitis in pregnant and non-pregnant women","volume":"10","author":"Babic","year":"2010","journal-title":"Bosn J Basic Med Sci"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-007-0554-7"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4049\/jimmunol.156.2.653","article-title":"helper 1 response against Leishmania major in pregnant C57BL\/6 mice increases implantation failure and fetal resorption: correlation with increased IFN-gamma and TNF and reduced IL-10 production by placental cells","volume":"156","author":"Krishnan","year":"1996","journal-title":"J Immunol"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.15","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh378"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2008.00669.x"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.17","doi-asserted-by":"crossref","unstructured":"Boomsma CM Keay SD Macklon NS . Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst Rev 2012;6. doi:10.1002\/14651858.CD005996.pub3.","DOI":"10.1002\/14651858.CD005996.pub3"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.18","first-page":"383","article-title":"Results of prednisolone given to improve the outcome of in vitro fertilisation-embryo transfer in women with antinuclear antibodies","volume":"50","author":"Taniguchi","year":"2005","journal-title":"J Reprod Med"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2012.04.002"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.20","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/18.3.364"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.21","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.2.336"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.22","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn157"},{"key":"2025042703062046000_2014.mar31_1.bcr2013203202.23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/pch\/13.3.181","article-title":"The ethics of using innovative therapies in the care of children","volume":"13","author":"Al Eyadhy","year":"2008","journal-title":"Paediatr Child Health"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2013-203202","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T10:06:29Z","timestamp":1745748389000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2013-203202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,31]]},"references-count":23,"alternative-id":["10.1136\/bcr-2013-203202"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2013-203202","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,31]]}}}